Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Istvan Enyedy

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitorsSharad Verma, Dhanapalan Nagarathnam, Jianxing Shao, et al.
Journal of Medicinal Chemistry|November 12, 2019
Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 InhibitorsMartin K Himmelbauer, Zhili Xin, J Howard Jones, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of biaryl carboxylamides as potent RORγ inverse agonistsJianhua Chao, Istvan Enyedy, Kurt Van Vloten, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2011
3,5-diarylazoles as novel and selective inhibitors of protein kinase DGabriel G Gamber, Erik Meredith, Qingming Zhu, et al.
Bioorganic & Medicinal Chemistry|May 8, 2013
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanismDouglas Marcotte, Weike Zeng, Jean-Christophe Hus, et al.
Journal of Medicinal Chemistry|October 15, 2021
Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation <i>In Vivo</i>J Howard Jones, Zhili Xin, Martin Himmelbauer, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2018
Investigating small molecules to inhibit germinal center kinase-like kinase (GLK/MAP4K3) upstream of PKCθ phosphorylation: Potential therapy to modulate T cell dependent immunityTricia L May-Dracka, Robert Arduini, Andrea Bertolotti-Ciarlet, et al.
ACS Chemical Neuroscience|February 22, 2023
Elucidation of the GSK3α Structure Informs the Design of Novel, Paralog-Selective InhibitorsBrenda Amaral, Andrew Capacci, Trip Anderson, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Discovery of Phospholipase D Inhibitors with Improved Drug-like Properties and Central Nervous System PenetranceTricia L May-Dracka, Fang Gao, Brian T Hopkins, et al.
Scientific Reports|September 9, 2018
Potent PDZ-Domain PICK1 Inhibitors that Modulate Amyloid Beta-Mediated Synaptic DysfunctionEdward Y S Lin, Laura F Silvian, Douglas J Marcotte, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitorsSharad Verma, Dhanapalan Nagarathnam, Jianxing Shao, et al.
Journal of Medicinal Chemistry|November 12, 2019
Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 InhibitorsMartin K Himmelbauer, Zhili Xin, J Howard Jones, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of biaryl carboxylamides as potent RORγ inverse agonistsJianhua Chao, Istvan Enyedy, Kurt Van Vloten, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2011
3,5-diarylazoles as novel and selective inhibitors of protein kinase DGabriel G Gamber, Erik Meredith, Qingming Zhu, et al.
Bioorganic & Medicinal Chemistry|May 8, 2013
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanismDouglas Marcotte, Weike Zeng, Jean-Christophe Hus, et al.
Journal of Medicinal Chemistry|October 15, 2021
Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation <i>In Vivo</i>J Howard Jones, Zhili Xin, Martin Himmelbauer, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2018
Investigating small molecules to inhibit germinal center kinase-like kinase (GLK/MAP4K3) upstream of PKCθ phosphorylation: Potential therapy to modulate T cell dependent immunityTricia L May-Dracka, Robert Arduini, Andrea Bertolotti-Ciarlet, et al.
ACS Chemical Neuroscience|February 22, 2023
Elucidation of the GSK3α Structure Informs the Design of Novel, Paralog-Selective InhibitorsBrenda Amaral, Andrew Capacci, Trip Anderson, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Discovery of Phospholipase D Inhibitors with Improved Drug-like Properties and Central Nervous System PenetranceTricia L May-Dracka, Fang Gao, Brian T Hopkins, et al.
Scientific Reports|September 9, 2018
Potent PDZ-Domain PICK1 Inhibitors that Modulate Amyloid Beta-Mediated Synaptic DysfunctionEdward Y S Lin, Laura F Silvian, Douglas J Marcotte, et al.
Pageof 3